KALA BIO, INC. Debt Instrument, Interest Rate, Effective Percentage
KALA BIO, INC. (KALA) had Debt Instrument, Interest Rate, Effective Percentage of 19.00% as of 2025-09-30, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2026-04-15
- 2025-09-30: Debt Instrument, Interest Rate, Effective Percentage 19.00%.
- 2025-06-30: Debt Instrument, Interest Rate, Effective Percentage 14.04%.
- 2025-03-31: Debt Instrument, Interest Rate, Effective Percentage 14.98%.
- 2024-12-31: Debt Instrument, Interest Rate, Effective Percentage 15.18%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2025-09-30 | 19.00% 10-K · filed 2026-04-15 |
| 2025-06-30 | 14.04% 10-Q · filed 2025-08-08 |
| 2025-03-31 | 14.98% 10-Q · filed 2025-05-14 |
| 2024-12-31 | 15.18% 10-K · filed 2025-03-31 |
| 2024-09-30 | 17.07% 10-Q · filed 2024-11-12 |
| 2024-06-30 | 17.21% 10-Q · filed 2024-08-06 |
| 2024-03-31 | 17.20% 10-Q · filed 2024-05-14 |
| 2023-12-31 | 17.22% 10-K · filed 2024-03-29 |
| 2023-09-30 | 17.21% 10-Q · filed 2023-11-13 |
| 2023-06-30 | 16.97% 10-Q · filed 2023-08-04 |
| 2023-03-31 | 16.44% 10-Q · filed 2023-05-09 |
| 2022-12-31 | 15.63% 10-K · filed 2023-03-03 |
| 2020-09-30 | 11.63% 10-Q · filed 2020-11-05 |
| 2020-06-30 | 11.63% 10-Q · filed 2020-08-06 |
| 2019-09-30 | 11.63% 10-Q · filed 2020-11-05 |
| 2019-06-30 | 11.63% 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |